Pasithea Therapeutics Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
/ 
Frequently asked questions
To buy Pasithea Therapeutics Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Pasithea Therapeutics Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Pasithea Therapeutics Corp. is KTTA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Pasithea Therapeutics Corp. has its primary listing on NASDAQ (Small cap). You can trade Pasithea Therapeutics Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Pasithea Therapeutics Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Pasithea Therapeutics Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Pasithea Therapeutics Corp..